Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medtecs International Corporation Limited (9103:TWSE), powered by AI.
Medtecs International Corporation Limited is currently trading at $5.46. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medtecs International Corporation Limited on Alpha Lenz.
Medtecs International Corporation Limited's P/E ratio is -624.4.
“Medtecs International Corporation Limited trades at a P/E of -624.4 (undervalued) with modest ROE of -4.6%.”
Ask for details →Medtecs International Corporation Limited is a leading integrated manufacturer and distributor of healthcare and personal protective equipment based in Asia. Since its founding in 1989, the company has specialized in producing high-quality medical and industrial textiles, including isolation gowns, coveralls, and surgical masks, crucial for ensuring the safety and protection of healthcare workers and patients. Medtecs' products are vital for sectors such as healthcare, industrial safety, and emergency response, underscoring their role in critical supply chains. The company has established a robust distribution network across the globe, servicing clients in Europe, Asia-Pacific, and the United States. By continuously enhancing their manufacturing processes and product offerings, Medtecs plays a significant role in supporting global public health infrastructure and readiness, particularly highlighted during health crises when demand for protective equipment surges. The company's commitment to innovation and quality supports its position as a trusted partner in the healthcare industry, contributing significantly to the safety supplies market worldwide.
“Medtecs International Corporation Limited trades at a P/E of -624.4 (undervalued) with modest ROE of -4.6%.”
Ask for details →Medtecs International Corporation Limited (ticker: 9103) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). Market cap is $3.0B.
The current price is 5.46 with a P/E ratio of -624.39x and P/B of 29.3x.
ROE is -4.59% and operating margin is -7.92%. Annual revenue is $79M.